|15 September, 2019

CPhI Middle East & Africa 2019 opens tomorrow in Abu Dhabi as MENA pharma market set to top US41 billion by 2022

Over 294 local, regional and international exhibitors from more than 35 countries and 4,900 industry professionals return to Abu Dhabi for leading global pharmaceutical exhibition

CPhI Middle East Africa 2019 opens tomorrow in Abu Dhabi as MENA pharma market set to top US41 billion by 2022

Abu Dhabi, United Arab Emirates: Pharmaceutical professionals from across the world will descend upon Abu Dhabi tomorrow (Monday 16th) for the opening of CPhI Middle East & Africa, the region’s leading platform for the pharmaceutical industry.

The event, which is returning for a second year after its successful launch in the capital last year, will take place at the Abu Dhabi National Exhibition Centre (ADNEC) from 16-18 September 2019. Sponsored by the Ministry of Health and Protection (MoHaP), CPhI is set to attract attendees from the Middle East and Africa (MEA) - of which the MENA region accounts for 4% of the global pharma market - and the rest of the world.

H.E. Sheikh Nahyan bin Mubarak Al Nahyan, Minister of Tolerance, will officially open this year’s CPhI Middle East & Africa before delivering a keynote address alongside H.E Dr. Amin Hussain Al Amiri, Assistant Undersecretary of Public Health Policy & Licensing Sector in UAE Ministry of Health & Prevention.

Speaking ahead of the opening, Cara Turner, Brand Director – Pharma, for Informa Markets the event organiser, said: “The pharmaceutical market in the UAE and the wider Middle East and Africa region is one of the most innovative in the world with research indicating the region’s pharma market will reach a projected value of around US$ 41.5 billion by 2022.

“In addition to providing a platform to meet, and to conduct business, this year’s CPhI Middle East & Africa will provide a platform to showcase the latest cutting-edge technologies and innovative healthcare solutions while exploring how new technological breakthroughs have the potential to save the healthcare, and indeed the pharmaceutical industry, billions of dollars over the next decade.”

CPhI Middle East & Africa, the region’s only event dedicated to pharma manufacturing, is the leading platform that brings together pharma ingredients, product manufacturers, suppliers and buyers covering every step of the pharma supply chain from drug research and discovery to finished dosage.

The exhibition space at CPhI is broken down into five distinct sectors of the pharmaceutical industry:

  • CPhI: Brings together buyers, manufacturers and suppliers of pharmaceutical ingredients
  • FDF: Meet with manufacturers from every aspect of the finished dosage supply chain
  • ICSE: Connects the pharma community with CRO and CMO companies and technologies
  • P-MEC: Showcases the newest pharmaceutical machinery, equipment and technology providers
  • InnoPack: Hosts the latest innovations in packaging, integrated solutions and drug delivery systems

Turner added: “The exhibition will also feature Live Pharma Connect, a free match and meet service open to visitors and exhibitors allowing both parties to make pre-arranged pharma specific, mutually beneficial meetings during the event. And, running in parallel to the exhibition will be a range of content sessions addressing the latest trends in the market, a range of keynote addresses, as well as a host of networking opportunities.”

A total of 14 sessions are scheduled for the three-day showcase, with the opening session on day one ‘Creating Regulatory Harmony across the Middle East & North Africa’ taking place from 10.30am – 12.45pm, discussing the steps that governments across the region can take to support the pharmaceutical industry and foster collaboration.

With Saudi Arabia’s pharma market expected to top US$ 10.74bn by 2023, a presentation titled ‘Delivering Saudi Arabia’s Vision 2030’ and delivered by Dr Faisal BinDail, Chairman of the National Committee for Pharmaceutical Industries, will discuss the incentives for stimulating local manufacturing in the Kingdom – while exploring the opportunities that this emerging manufacturing sector presents.

Meanwhile, the final day will be dominated by the latest cutting-edge technologies and innovations in the pharmaceutical industry, with a session titled ‘Innovation vs Generics’ exploring the steps the region must take to continue being an innovator market and how this can be achieved whilst still being mindful of healthcare spending.

Media wishing to attend the event can register here.

The event takes place from 16-18 September at the Abu Dhabi National Exhibition Centre. For further information please visit www.cphi.com/mea

ENDS

About CPhI
CPhI drives growth and innovation at every step of the global pharmaceutical supply chain from drug discovery to finished dosage. Through exhibitions, conferences and online communities, CPhI brings together more than 100,000 pharmaceutical professionals each year to network, identify business opportunities and expand the global market. CPhI hosts events in Europe, North America, Korea, China, India, Japan, Southeast Asia and the Middle East, and co-locates with ICSE for contract services, P-MEC for machinery, equipment & technology, FDF for finished dosage formulations, InnoPack for pharmaceutical packaging and BioPh for biopharma. CPhI provides an online buyer & supplier directory at CPhI-Online.com. 

For more information visit: www.cphi.com 

About Informa Markets
Informa Markets creates platforms for industries and specialist markets to trade, innovate and grow. Our portfolio is comprised of more than 550 international B2B events and brands in markets including Healthcare & Pharmaceuticals, Infrastructure, Construction & Real Estate, Fashion & Apparel, Hospitality, Food & Beverage, and Health & Nutrition, among others. We provide customers and partners around the globe with opportunities to engage, experience and do business through face-to-face exhibitions, specialist digital content and actionable data solutions. As the world’s leading exhibitions organiser, we bring a diverse range of specialist markets to life, unlocking opportunities and helping them to thrive 365 days of the year. For more information, please visit www.informamarkets.com

 Media contact
JAMES LAKIE
General Manager
Tel: +971 4 365 2711 | Mobile: +971 50 153 6544
E-mail: james.lakie@shamalcomms.com
Office 106, Arjaan Office Tower, Dubai Media City
PO Box 502701 | Dubai, United Arab Emirates
Website: www.shamalcomms.com

© Press Release 2019

Disclaimer: The contents of this press release was provided from an external third party provider. This website is not responsible for, and does not control, such external content. This content is provided on an “as is” and “as available” basis and has not been edited in any way. Neither this website nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this press release.

The press release is provided for informational purposes only. The content does not provide tax, legal or investment advice or opinion regarding the suitability, value or profitability of any particular security, portfolio or investment strategy. Neither this website nor our affiliates shall be liable for any errors or inaccuracies in the content, or for any actions taken by you in reliance thereon. You expressly agree that your use of the information within this article is at your sole risk.

To the fullest extent permitted by applicable law, this website, its parent company, its subsidiaries, its affiliates and the respective shareholders, directors, officers, employees, agents, advertisers, content providers and licensors will not be liable (jointly or severally) to you for any direct, indirect, consequential, special, incidental, punitive or exemplary damages, including without limitation, lost profits, lost savings and lost revenues, whether in negligence, tort, contract or any other theory of liability, even if the parties have been advised of the possibility or could have foreseen any such damages.

More From Press Releases